Study of an investigational drug in healthy adults
Part of Brain & nervous system, Mental health clinical trials.
This study tests an investigational drug called GSM-779690T in healthy adults. It aims to understand how the drug works in the body and check for any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old and in good health.
- You can read, speak, and understand English well enough to follow instructions and take tests.
- You are willing to stay in the clinic for the study procedures.
- If you are a woman who could become pregnant, you must use highly effective birth control and have a negative pregnancy test.
- If you are a man with a partner who could become pregnant, you must use effective birth control or abstain from sex during the study and for one week after the last dose.
- You have no history of major medical conditions like heart, liver, kidney, or psychiatric disease, and no current suicidal thoughts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called NSC001 for people with mild to moderate Alzheimer's. It checks if the drug is safe and if it might help slow memory decline. You'll need a caregiver who can join you at visits and help track your progress.
This study tests an experimental drug for Alzheimer's called NTRX-07. It aims to see if it can slow memory decline for people with mild to moderate Alzheimer's.
This study tests a new drug (BnH-015B) for people with moderate Alzheimer's disease. It also includes a small group of healthy young men for comparison. The goal is to see if the drug is safe and how it works in the body.
This trial tests a new drug called CM383 in people with mild cognitive impairment or mild Alzheimer's disease. The goal is to see if it can help slow down memory loss.
This study tests an investigational drug, ARO-MAPT-SC, which targets a protein involved in Alzheimer's disease. It is for people with early Alzheimer's to see if the drug is safe and can slow the disease.
This Phase 2 study tests whether sargramostim (a GM-CSF related medicine) is safe and can slow or improve Alzheimer’s symptoms. You might be a good fit if you have mild or moderate Alzheimer’s, positive amyloid testing, and can complete frequent visits with a close caregiver who knows you well.
Hear when a new Healthy Adult Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.